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Abstract
MicroRNAs have been shown to be important regulators of inflammatory and immune responses and are implicated in
several immune disorders including systemic lupus erythematosus and rheumatoid arthritis, but their role in Lyme
borreliosis remains unknown. We performed a microarray screen for expression of miRNAs in joint tissue from three mouse
strains infected with Borrelia burgdorferi. This screen identified upregulation of miR-146a, a key negative regulator of NF-kB
signaling, in all three strains, suggesting it plays an important role in the in vivo response to B. burgdorferi. Infection of B6
miR-146a2/2 mice with B. burgdorferi revealed a critical nonredundant role of miR-146a in modulating Lyme arthritis
without compromising host immune response or heart inflammation. The impact of miR-146a was specifically localized to
the joint, and did not impact lesion development or inflammation in the heart. Furthermore, B6 miR-146a2/2 mice had
elevated levels of NF-kB-regulated products in joint tissue and serum late in infection. Flow cytometry analysis of various
lineages isolated from infected joint tissue of mice showed that myeloid cell infiltration was significantly greater in B6 miR-
146a2/2 mice, compared to B6, during B. burgdorferi infection. Using bone marrow-derived macrophages, we found that
TRAF6, a known target of miR-146a involved in NF-kB activation, was dysregulated in resting and B. burgdorferi-stimulated
B6 miR-146a2/2 macrophages, and corresponded to elevated IL-1b, IL-6 and CXCL1 production. This dysregulated protein
production was also observed in macrophages treated with IL-10 prior to B. burgdorferi stimulation. Peritoneal macrophages
from B6 miR-146a2/2 mice also showed enhanced phagocytosis of B. burgdorferi. Together, these data show that miR-146a-
mediated regulation of TRAF6 and NF-kB, and downstream targets such as IL-1b, IL-6 and CXCL1, are critical for modulation
of Lyme arthritis during chronic infection with B. burgdorferi.
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Introduction
Lyme Disease is caused by infection with Borrelia burgdorferi, a tick-
borne spirochete [1], and is the most common vector-borne disease in
the United States with an estimated 300,000 cases per year [2].
Often, infection leads to acute arthritis in humans. Clinical
manifestations of Lyme arthritis include inflammatory cell infiltration,
edema, synovial hyperplasia and remodeling of bone and connective
tissue [3,4]. In some cases, infection can induce autoimmunity,
despite treatment with antibiotics [5]. The reason why arthritis fails to
resolve remains poorly understood, but is believed to be the result of
dysregulation of host immune response to infection [6].
Several inbred mouse strains exhibit varying degrees of disease
severity similar to human patients [7,8]. Whereas the C57BL/6
(B6) mouse strain develops mild arthritis, C3H and various
knockout strains such as B6 IL102/2 mice develop moderate to
severe arthritis [7,9]. Furthermore, the intensity of the inflamma-
tory response for a given spirochete burden varies greatly among
strains, implicating host immune response as driving arthritis
development [9,10]. Our laboratory and others have used the
mouse model system to elucidate key regulators of host immune
response to infection.
Since its discovery, nuclear factor-kappa B (NF-kB) has been
identified as a key regulator in many cellular functions including
inflammation and cancer [11]. B. burgdorferi lipoproteins are
extremely potent activators of Toll-like receptor 2 (TLR2)-
mediated NF-kB activation and cytokine production, and are
important for host defense [12–16]. Mice lacking TLR2 or the
adapter protein myeloid differentiation primary response gene (88)
(MyD88) exhibit a failure to control infection [14,17–21].
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Although these knockout studies clearly demonstrate an important
role of NF-kB in host defense, elucidating its role in inflammation
and Lyme arthritis has remained elusive.
While NF-kB activation is critical in response to infection,
downregulation is equally important to avoid excess inflamma-
tion, tissue damage and autoimmunity [22]. MicroRNAs
(miRNAs) have recently been identified as being important
regulators of NF-kB [23] and autoimmunity [24]. These small
regulatory RNAs are posttranscriptional regulators of gene
expression [25], and one miRNA, miR-146a, has been shown
to be a modulator of innate immune response to TLR ligands
[26]. Targets of miR-146a include TNF receptor associated
factor 6 (TRAF6) and IL-1 receptor associated kinase 1
(IRAK1), adaptor molecules downstream of the MyD88-
dependent TLR and cytokine signaling pathways [27]. Impor-
tantly, miR-146a itself is upregulated by IL-1b and TLRs,
including TLR2, and thus acts as a negative feedback regulator
of NF-kB signaling which is required for immune homeostasis
in vivo [27–31].
Aberrant microRNA expression, particularly miR-146a, has
been associated with a variety of inflammatory disorders [32].
In systemic lupus erythematosus, a functional variant in the
miR-146a promoter is associated with disease risk [33], and
abnormally low miR-146a expression has been associated
with more severe symptoms [34]. In contrast, rheumatoid
arthritis synovial fibroblasts express abnormally high levels of
miR-146a [35,36], while osteoarthritis chondrocytes express
variable levels miR-146a, correlating with disease severity
[37,38].
Despite correlative evidence linking aberrant miRNA expres-
sion to diseases such as lupus, RA and OA, determining whether
miRNAs play an active role in pathogenesis has yet to be
elucidated, and to our knowledge, no studies have examined the
role of miRNAs in Lyme arthritis. For these reasons, we sought to
determine whether changes in miRNA expression contributed to
host defense and Lyme arthritis development during B. burgdorferi
infection.
Results
miR-146a is highly upregulated in B6, C3H and B6
IL102/2 mice during infection
MicroRNA dysregulation has been associated with a number of
inflammatory disorders, and we hypothesized that these may play
an important role in response to B. burgdorferi infection and Lyme
arthritis development. We therefore performed a genome-wide
screen of changes in miRNA expression in joints of B6, C3H and
B6 IL-102/2 mice infected with B. burgdorferi at one and two weeks
post-infection using an Agilent mouse microRNA microarray
(Table 1, Table S1). MicroRNAs differentially regulated included
many that have been identified previously as important regulators
of immune function. Interestingly, each infection model had a
unique miRNA expression ‘‘signature,’’ and we found that only a
few dozen miRNAs showed changes in expression during
infection. Most of these changes were in C3H mice, and may be
due to both differences in inflammatory response and intrinsic
differences in miRNA function between strains. At two weeks post-
infection, two miRNAs, miR-21 and miR-146a, both induced by
NF-kB and associated with TLR signaling, were the most highly
upregulated in all three strains (Table 1), and were confirmed
using qRT-PCR (Figure 1). Furthermore, these miRNAs main-
tained high expression, even at 4 weeks post-infection. Interest-
ingly, miR-155 was significantly upregulated in B6 IL102/2 mice,
but not in B6 or C3H mice. This microRNA is a proinflammatory
NF-kB-induced miRNA associated with T cell-dependent inflam-
mation and autoimmunity [39–41], and expression is suppressed
by IL-10 [42].
Of these, miR-146a was of particular interest, given recent
reports showing a link between miR-146a and susceptibility to a
variety of inflammatory disorders. Targets of miR-146a, IRAK1
and TRAF6 [27], are involved in TLR2/NF-kB activation, which
is an important pathway in controlling B. burgdorferi infection
[13,14,17–21]. Also, the observation that miR-146a was upregu-
lated in all three strains suggested that this miRNA likely plays a
general role in regulating the immune response to B. burgdorferi. For
these reasons, our focus turned to studying miR-146a. A B6 miR-
146a2/2 knockout mouse was recently generated [28], which
provided a powerful tool to evaluate the role of miR-146a in
mildly arthritic B6 mice. While miR-146a was also upregulated in
arthritis-susceptible C3H mice, we suspected that other genetic
factors play a dominant role in arthritis development, including
excessive Type I IFN production [43,44] and accumulation of
undigested glycosaminoglycans in joint tissue [45]. These effects
may limit the ability of miR-146a to modulate arthritis develop-
ment in the C3H mouse model. It is tempting to speculate,
however, that lack of miR-146a in the arthritis-susceptible C3H
mouse would lead to even more severe arthritis, as has been
reported in the C3H IL-102/2 mouse model [46].
Impact of miR-146a on Lyme arthritis, carditis and host
defense
Since miR-146a is an important negative regulator of NF-kB
activation, we hypothesized that a B6 mouse deficient in miR-146a
would develop more severe arthritis during infection with B.
burgdorferi compared to WT controls. To avoid age-related
pathologies associated with B6 miR-146a2/2 mice [30], we used
6–8 week-old mice, which is also the age of optimal arthritis in
other mouse strains. Arthritis was assessed in B. burgdorferi-infected
B6 and B6 miR-146a2/2 mice. At four weeks post-infection, B6
miR-146a2/2 mice developed significantly more severe arthritis.
Several markers of arthritis were elevated in B6 miR-146a2/2
mice, including ankle swelling (Figure 2A), number and severity of
Author Summary
Lyme Disease is caused by infection with the bacteria
Borrelia burgdorferi, is transmitted through infected deer
ticks (Ixodes scapularis), and often leads to arthritis that can
persist, even after antibiotic treatment. Here, we have
identified a microRNA that is critical in modulating Lyme
arthritis, but not carditis. This microRNA, miR-146a, is a
negative regulator of NF-kB signaling, known to be
important in host defense against pathogens, and long
suspected to play a role in Lyme arthritis development.
Mice lacking miR-146a develop more severe arthritis and
show signs of hyperactive NF-kB activation during the
persistent phase of infection. Heart manifestations of
disease were not altered. Furthermore, this severe arthritis
is independent of host defense, since these mice are better
able to clear invading bacteria in joints, and bacterial
numbers are similar in heart and ear tissue. We identified
TRAF6 as an important target of miR-146a-mediated NF-kB
regulation of pro-inflammatory cytokines IL-6 and IL-1b, as
well as chemokines CXCL1 and CXCL2. Our data demon-
strate the importance of maintaining appropriate regula-
tion of amplitude and resolution of NF-kB activation
during Borrelia burgdorferi infection, and provide a novel
model for elucidating the role of NF-kB in Lyme arthritis
development, independent of effect on host defense.
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lesions observed, polymorphonuclear (PMN) cell infiltrate, reac-
tive/reparative score (periosteal hyperplasia and new bone
formation and remodeling), and tendon sheath thickness
(Table 2). Cranial tibial tendon is enlarged in Figure 2B. Control
(BSK-injected) mice showed no significant arthritis in either
strain, and no significant difference between strains was seen in
mononuclear cell infiltrate into inflammatory processes. Impor-
tantly, B6 miR-146a2/2 mice did not display overwhelming
numbers of bacteria; rather, they tended to have somewhat fewer
bacteria in infected joints and similar burden in infected heart and
ear tissue, as measured by B. burgdorferi-specific16S rRNA normal-
ized to b-actin in joints and heart, and recA normalized to mouse
nidogen in ear tissue (Figure 2C). This difference in bacterial load in
joint tissue was likely not due to differences in antibody response,
since B. burgdorferi-specific IgM and IgG levels were similar
between the two strains at two weeks and four weeks post-
infection, respectively (Figure 2D). While this does not rule out the
possibility that different borrelial proteins could be opsonic targets
in the two strains, these data support the notion that increased
arthritis observed in B6 miR-146a2/2 mice was likely due to a
defect in regulation of host immune function rather than
compromised host defense. In fact, the decrease in 16S rRNA in
B6 miR-146a2/2 mouse joints indicated that arthritis develop-
ment was independent of bacterial density. This increased arthritis
severity with accompanying decreases in bacterial burden is also
observed in the B6 IL102/2 mouse model of arthritis [9,47,48],
and is believed to be due primarily to enhanced innate immune
responses [49].
In addition to joints, the heart is another target of B. burgdorferi
infection in mice. We therefore looked for evidence of miR-146a
modulating inflammation in heart tissue. Mice are susceptible to
Lyme carditis in an MHC-independent manner, and exhibit
variation in disease severity, with C3H mice harboring a greater
number of bacteria and developing more severe carditis and B6
mice being resistant and harboring fewer bacteria [7,50,51]. Lyme
carditis is also observed in humans, and although rare, can be
fatal [52]. To assess the role of miR-146a in modulating heart
inflammation, B6, B6 miR-146a2/2 and C3H mice were infected
with B. burgdorferi for 3 weeks and hearts were removed and
assessed for bacterial numbers and changes in transcripts of
inflammatory genes. As was seen at 4 weeks post-infection
(Figure 2C), bacterial burden, as measured by qRT-PCR analysis
of B. burgdorferi 16S rRNA, was similar between B6 and B6 miR-
146a2/2 mice, and both trended lower than what was seen in
heart tissue from C3H mice (Figure 3A). Lesions in the heart were
also scored for carditis in B6, B6 miR-146a2/2 and C3H mice at 3
weeks post-infection. Overall lesion scores were similar in B6 and
B6 miR-146a2/2 mice, and both trended lower than lesion
severity in C3H mice (Figure 3B).
Lesions in hearts at 3 weeks post-infection were characterized by
acute to subacute vasculitis/perivasculitis (see Figure 3C) of the 1)
microvasculature (capillaries) at the base of the heart (in heart
muscle) where the aorta and pulmonary arteries arise, 2)
microvasculature (capillaries) within connective tissues supporting
these arteries, and 3) microvasculature (capillaries) of the vasa
vasorum of the aorta and pulmonary arteries. These lesions
Figure 1. PCR validation of miRNA microarray results. qRT-PCR analysis of miR-146a, miR-21 and miR-155 expression normalized to 5S rRNA
from B. burgdorferi-infected joints of B6, C3H and IL102/2 mice at 1, 2, or 4 weeks post-infection (n = 3–4). Shown is fold change in expression
compared to uninfected controls 6 SEM. * indicates statistically significant increase in expression vs. uninfected controls by ANOVA followed by
Dunnett’s post-hoc test, a=0.05.
doi:10.1371/journal.ppat.1004212.g001
Table 1. MicroRNAs most highly changed in expression, based on microarray, in joints of different mouse strains.
B6 C3H IL-102/2
miRNA Fold D miRNA Fold D miRNA Fold D
miR-146a 5.67 miR-146a 10.8 miR-21 6.08
miR-21 3.92 miR-21 8.12 miR-146a 5.34
miR-706 3.47 miR-142-3p 6.54 miR-155 5.12
miR-29b 2.31 miR-142-5p 4.99 miR-193b 23.04
miR-715 2.24 miR-34a 4.4 miR-150 22.56
miR-340-5p 2.21 miR-18a 3.35 miR-145 22.43
miR-34a 2.16 miR-19b 3.08 miR-181a 22.37
miR-689 2.12 miR-145 23.07 miR-181b 22.29
List of 8 most highly differentially expressed miRNAs in B. burgdorferi-infected joints of B6, C3H and B6 IL-102/2 mice at two weeks post-infection, based on Agilent
mouse miRNA microarray. Shown is fold-change in expression compared to uninfected controls. Significance was determined using Welch’s t-test with Benjamini and
Hochberg correction (p,0.05, n = 3–4 mice per group).
doi:10.1371/journal.ppat.1004212.t001
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affected the vascular system, rather than being primary lesions of
the heart muscle (myocarditis). The character and pattern of
distribution of these lesions suggested that inflammation of the
microvasculature is the result of some type of localized target cell
(i.e., endothelium) or target substance (i.e., bacteria) specificity for
this location consistent with Borrelial adhesin-host ligand binding
within the vascular endothelium [53,54]. Vascular turbulence or
oxygen concentration could also be involved.
Lyme carditis is associated with macrophage infiltration [50],
and invariant NKT cells have been shown to play a protective role
in B6 mice [55]. We therefore used PCR analysis of macrophage
(CD11b and F4/80) and NKT cell (CD4 and Va14) markers to
assess changes in cellularity in infected heart tissue (Figure 3D), as
performed previously [56,57]. Significant upregulation of macro-
phage markers CD11b and F4/80 was observed in all three strains,
as expected based on previous research [50]. The magnitude of
upregulation was not different between B6 and miR-146a deficient
mice, indicating no role of miR-146a feedback on inflammation in
this tissue. Interestingly, while CD11b and F4/80 transcripts were
also significantly upregulated in C3H mice, the degree of
upregulation was somewhat less than upregulation observed in
B6 and B6 miR-146a2/2 mice at 3 weeks post-infection. Because
these data are from whole heart tissue, they reflect cumulative
changes in myeloid cell numbers from the entire heart, including
changes in resident cardiac macrophages [58], which may dilute
out lesion-specific changes identified by histopathology.
CD4 transcript levels were not significantly different between
strains, but while both B6 and B6 miR-146a2/2 mice contained
similar levels of Va14 that trended higher at 3 weeks, C3H mice
had very low levels of this transcript in both uninfected and
infected heart tissue. This is consistent with significant variation of
NKT cell numbers between different mouse strains [57]. PCR
analysis was also used to determine changes in expression of
various inflammatory cytokines and chemokines in heart tissue
(Figure 3D). As previously reported, C3H mice had elevated levels
of IFNc transcripts in infected heart tissue [59], which was
significantly higher than IFNc mRNA in B6 and B6 miR-146a2/2
hearts. This trend was also observed for IL6 transcripts, although
there was significant variation in expression within C3H mice. No
differences among B6, B6 miR-146a2/2 and C3H mice were
observed for transcripts of IL1b, TNFa, Cxcl1, Cxcl2, Ccl2, IL10 or
IL12 (data not shown). Together, these data suggest that the nature
of host defense, macrophage and NKT cell proliferation and
infiltration, as well as cytokine and chemokine expression, is very
similar in infected B6 and B6 miR-146a2/2 heart tissue, but is
quite distinct from observations in carditis-susceptible C3H mice.
Fundamental differences between strains have been reported
previously in Lyme carditis studies comparing the effect of Stat1
[60] and Ccr2 [51] deficiencies on carditis-susceptible and carditis-
resistant mouse strains. Together, these data show that while
strain-specific variables influence differences in carditis suscepti-
bility between B6 and C3H mice, miR-146a has no impact on
carditis severity in B6 mice.
B6 miR-146a2/2 mice exhibit hyperactive expression of
NF-kB target cytokines and chemokines at 4 weeks post-
infection
Because miR-146a is known to negatively regulate NF-kB
activation, we compared transcripts of genes upregulated by NF-
kB in infected joint tissue from B6 and B6 miR-146a2/2 mice at 2
and 4 weeks post-infection. We observed that a number of NF-kB
inducible genes were significantly elevated at 4 weeks post-
infection (but not at 2 weeks) by qRT-PCR in B6 miR-146a2/2
joints, compared to WT, including cytokines IL-1b and IL-6, as
well as neutrophil chemokines Cxcl1 and Cxcl2 (Figure 4A).
CXCL1 has been shown to be required for full arthritis
development in C3H mice [61,62], and increased expression of
this gene in B6 miR-146a2/2 mice could be directly contributing
to arthritis development through recruitment of neutrophils. This
is supported by the increase in PMN infiltrate seen at 4 weeks by
histopathology, shown in Table 2. Elevated IL-1b transcript level
is also particularly interesting, since the IL-1 receptor (IL-1R) uses
the same adaptors as TLR2/1 for signal transduction, is strongly
upregulated by myeloid cells during phagocytosis of B. burgdorferi
[63], and is dependent on IRAK1 and TRAF6, two miR-146a
targets [27]. Furthermore, IL-1b stimulates miR-146a upregula-
tion in vitro [27], suggesting that this miRNA negatively regulates
Figure 2. B6 miR-146a2/2 mice develop more severe arthritis at 4 weeks post-infection independent of bacterial burden. Arthritis
severity was determined for B. burgdorferi-infected B6 or B6 miR-146a2/2 mice at 4 weeks post-infection. (A) Blinded measurements of rear ankles of
mice were taken before infection and at 4 weeks post-infection, and change in ankle measurement is shown. (B) Representative images of H&E-
stained tibiotarsal joints from BSK-injected (control) and 4 week-infected B6 and B6 miR-146a2/2 mice used for histopathology scoring (see Table 2).
Cranial tibial tendons of infected joints are enlarged to show detail of tendon sheath thickening and PMN infiltrate. (C) Bacterial burden was
determined by quantifying B. burgdorferi-specific 16S rRNA normalized to 1000 b-actin for joint and heart tissue, and recA, normalized to 1000 nidogen
for ear tissue. Pooled from two independent infection experiments (n$9 mice per experiment) for joints, and from one experiment for heart and ear
tissue (n = 5 mice). Statistical significance was determined by Student t test (*p,0.01). (D) Antibody concentrations were estimated in serum collected
from B. burgdorferi-infected B6 and B6 miR-146a2/2 mice as described in materials and methods. IgM was measured at 2 weeks post-infection (n = 4)
and IgG was measured at 4 weeks post-infection (n = 9–10). Data are representative of 2 independent experiments (n.s.: no significant difference
between strains).
doi:10.1371/journal.ppat.1004212.g002
Table 2. Histopathology scores of arthritis severity for B6 and B6 miR-146a2/2 mice.
Strain Overall Lesion PMN Infiltrate
Mono-nuclear
Infiltrate Sheath Thickness Reactive-Reparative Total Score
B6 1.53 (.21) 1.05 (.25) 0.58 (.14) 1.42 (.22) 0.26 (.15) 4.84 (.79)
miR-146a2/2 2.84 (.26) 2.21 (.26) 0.37 (.11) 2.74 (.26) 1.58 (.25) 9.74 (.97)
Histopathology scores of rear ankle joints of B6 and B6 miR-146a2/2 mice infected with B. burgdorferi for 4 weeks. Scores of 0–5, with 5 being most severe, were
assigned to each sample. Total score is the sum of scores from each category. Values shown are the mean (6SE), and bold numbers indicate statistically significant
difference between strains using Mann-Whitney U test (p,0.01), pooled from two independent infection experiments (n = 9–10 each).
doi:10.1371/journal.ppat.1004212.t002
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Figure 3. B6 and B6 miR-146a2/2 mice have similar B. burgdorferi burden and similar levels of inflammation in heart tissue, distinct
from C3H mice. Mice were infected with B. burgdorferi for 3 weeks, after which hearts were collected for analysis of bacterial burden and
inflammation. (A) Bacterial presence was quantified with B. burgdorferi-specific 16S rRNA, normalized to 1000 b-actin by qRT-PCR. (B) Carditis was
blindly assessed using histopathologic evaluation to score lesion severity in heart tissue from B6, B6 miR-146a2/2 and C3H mice infected with B.
miR-146a Is a Critical Modulator of Lyme Arthritis
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IL-1b signaling. It is important to note that uninfected B6 miR-
146a2/2 mice did not exhibit any abnormalities in expression of
these genes, indicating that this hyperactivity is due to a failure to
down-regulate the NF-kB response after infection, rather than
general NF-kB hyperactivity, as is observed in aging B6 miR-
146a2/2 mice [30].
Only a distinct subset of inflammatory cytokines and chemo-
kines (IL-1b, IL-6, Cxcl1, Cxcl2) appeared to be dysregulated in B6
miR-146a2/2 joints. Transcript levels of other Lyme arthritis-
associated genes (IFNc, Cxcl10, TNFa) were very similar between
the two strains (Figure 4A), and showed a peak in expression at 2
weeks post-infection, followed by resolution at 4 weeks. This is in
contrast to arthritis-susceptible B6 IL102/2 mice, where previ-
ously published data show that in addition to upregulation in IL-
1b, IL-6, Cxcl1 and Cxcl2, IFNc and Cxcl10 are upregulated 16-fold
and 141-fold at 2 weeks, and 22-fold and 189-fold at 4 weeks,
respectively [47]. These data together indicate that the B6 miR-
146a2/2 mouse is distinct from the B6 IL102/2 model, which is
associated with a dramatic IFNc signature in joints and elevation
of IFNc in serum at 4 weeks p.i. [47,48].
In order to determine whether there was systemic dysregulation
of NF-kB-inducible cytokines, serum was collected from B.
burgdorferi-infected mice at 4 weeks post-infection and cytokine
levels were measured by enzyme-linked immunosorbent assay
(Figure 4B). B6 miR-146a2/2 mice contained higher levels of IL-6
at 4 weeks post-infection, compared to wild-type, consistent with
observations in joint tissue. TNFa and IL-12 serum levels were
very similar between strains, and although levels of IFNc varied
widely in B6 miR-146a2/2 mice, they were not significantly
greater than B6 levels.
Effect of miR-146a in cell populations isolated from joints
early in infection
To identify the effect of miR-146a in various joint cell
populations during the early phase of infection ex vivo, we digested
joints with purified collagenase to release cells into a single-cell
solution in order to identify and isolate cell fractions based on
lineage markers, including CD45 for leukocytes, CD11b for
myeloid cells, CD31 for endothelial cells, and CD29 for fibroblast-
enriched cells (Figure 5A). This method has been used in C3H
mice to identify cellular sources of genes associated with the
arthritogenic Type I IFN response early in infection, and is a
sensitive assay to observe cell type-specific effects ex vivo that might
be missed using whole joint tissue [43]. Using this method, we
were able to determine the effect of miR-146a on specific cell types
early in infection (Figure 5B). Levels of IL-1b, while trending
higher in myeloid cells isolated from B6 miR-146a2/2 mice, were
not significantly different between the two strains. In B6 mice,
three genes, Cxcl2 and the IFN-inducible gene Oasl2 (in myeloid
cells) and Cxcl1 (in fibroblasts), tended to peak in expression at Day
7 post-infection. In contrast, transcripts were somewhat higher in
uninfected B6 miR-146a2/2 cell fractions vs. WT, and remained
elevated throughout infection. This suggests that B6 miR-146a2/2
mice may be poised to initiate a hyperactive immune response.
There was no difference in lymphoid IFNc expression between
strains, which peaked at Day 14 post-infection, as was seen in
whole joint tissue (Figure 4A). It is important to note that, unlike
published observations in C3H mice [43], B6 miR-146a2/2 mice
did not exhibit a robust induction of IFN-responsive genes, such as
Oasl2, in fibroblasts or endothelial cells at Day 7 post-infection
(data not shown). Overall, these data, combined with data from
Figure 4, suggest that a number of NF-kB-inducible genes in B6
miR-146a2/2 mouse joints are poised for hyper-activation prior to
infection, and peak at 4 weeks post-infection, indicating that miR-
146a acts to resolve the inflammatory response late in infection,
rather than limiting the amplitude of inflammation during early
stages of infection.
Myeloid cell recruitment is increased in infected joints of
B6 miR-146a2/2 mice
During cell sorting, we observed differences in cellular infiltrate,
particularly in the myeloid cell lineages, in joints during infection.
Therefore, a more rigorous analysis of myeloid cells recruited to
the joint by flow cytometry was performed at various times during
infection. Using joint cell isolation methods described in Figure 5,
myeloid cells were characterized from infected joints at 2 and 4
weeks post-infection using fluorescently labeled antibodies against
CD11b, F4/80, Ly6C, Gr1 and CD206. CD11b+ myeloid cell
populations clustered roughly into three populations, F4/80+
Ly6Clo macrophages, Gr1hi Ly6Cint PMNs and Gr1int Ly6Chi
monocytes (Figure 6A&B). Furthermore, F4/80+ Ly6Clo macro-
phages expressed variable levels of CD206 (MRC1, Mannose
Receptor C type 1), a marker of alternatively activated (M2-like)
macrophages [64]. There was little difference between strains in
mean fluorescence intensity (MFI) of MRC1 and Gr1 in each
myeloid subpopulation, suggesting that they were phenotypically
similar populations. However, while the number of these three
myeloid populations in B6 mouse joints changed only modestly in
B6 mice, myeloid cell numbers in B6 miR-146a2/2 joints were
significantly elevated at both 2 and 4 weeks post-infection
(Figure 6C). An increased trend in PMN infiltration in B6 miR-
146a2/2 mice is also consistent with histopathology data shown in
Table 2, despite the propensity of PMNs to lyse during enzymatic
digestion of joint tissue, resulting in some sample-to-sample
variation. Interestingly, there was little difference between strains
in infiltrating lymphoid cells at 2 or 4 weeks post-infection (Figure
S1). These data, as well as the observation of similar B. burgdorferi-
specific antibody levels (Figure 2D), suggest that arthritis and host
defense phenotypes observed in B6 miR-146a2/2 mice shown in
Figure 2 and Table 2 are driven primarily by myeloid cells.
Bone marrow-derived macrophages from B6 miR-146a2/2
mice are hyper-responsive to B. burgdorferi and have
elevated protein levels of TRAF6
The data from Figure 6 implicated myeloid cells as contributors
of arthritis development in B6 miR-146a2/2 mice. We therefore
turned to bone marrow-derived macrophages (BMDMs) to
elucidate the molecular mechanism of miR-146a regulation of
NF-kB during B. burgdorferi infection. BMDMs were cultured from
bone marrow extracted from B6 or B6 miR-146a2/2 mice and
treated with B. burgdorferi for 6 and 24 hours. We then measured
transcripts of IL1b, IL6 and TNFa (Table 3). Transcripts of IL1b
burgdorferi for 3 weeks. (C) H&E-stained sections of infected B6, B6 miR-146a2/2, and C3H hearts (106magnification top row, 406magnification
bottom row), with the intraventricular septum (ivs), coronary artery (ca), pulmonary artery (pa) and aorta (a) labeled as indicated. The inflammatory
response in these lesions was a mixture of neutrophils and mononuclear inflammatory cells such as lymphocytes and macrophages. (D) Transcripts
for CD11b, F4/80, CD4 and Va14, IFNc and IL6 were measured by qRT-PCR, normalized to b-actin. 4 mice were used for each strain, and statistically
significant difference between groups by ANOVA followed by Tukey’s post-hoc test are indicated (*p,0.05). For lesion scoring, Mann-Whitney U test
was used to determine whether there were statistical significant differences between groups, with p value indicated (n = 4 mice per strain).
doi:10.1371/journal.ppat.1004212.g003
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Figure 4. B6 miR-146a2/2 mice exhibit hyperactive expression of a subset of NF-kB target cytokines and chemokines at 4 weeks
post-infection. (A) RNA was isolated from B. burgdorferi-infected rear ankle joints at 2 and 4 weeks post-infection and transcript levels of IL6, IL1b,
Cxcl1, Cxcl2, IFNc, Cxcl10 and TNFa were measured by qRT-PCR, normalized to b-actin. (B) Serum from B. burgdorferi-infected mice was collected by
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were approximately 4-fold higher in B6 miR-146a2/2 BMDMs,
vs. WT, at both 6 and 24 hours, and IL6 levels were 7.5-fold
higher at 6 hours and 2.5-fold higher at 24 hours post-stimulation.
Interestingly, TNFa transcripts were only 20–30% higher in B6
miR-146a2/2 BMDMs, compared to WT. Transcripts for all
three cytokines were very low in uninfected cells, and were similar
between the two strains (data not shown). This suggests that miR-
146a effect on IL1b and IL6 regulation is greater than its effect on
TNFa expression.
We also measured levels of several NF-kB-inducible cytokines
by ELISA in cell supernatant from both B6 and B6 miR-146a2/2
BMDMs at 24 hours post-stimulation, including TNFa IL-1b, IL-
6 and IL-12, CXCL1 and IL-10 (Figure 7A). After 24 hours of
treatment with B. burgdorferi, three cytokines, IL-1b, IL-6 and IL-
12, and the neutrophil chemokine CXCL1, were more abundant
in B6 miR-146a2/2 cell supernatant than in B6 cell supernatant,
consistent with hyperactive NF-kB activation and transcript
analysis (Table 3). Interestingly, TNFa, an early-response NF-kB
cytokine, did not share this trend, which may be due to the
relatively late time point used for this analysis [65]. Production of
IL-10 was robust in both strains, although somewhat greater in
miR-146a-deficient BMDMs.
Previous work from our laboratory showed that many
macrophages are IL-10 producers in joints of B6 mice [48]. Also,
macrophages produce high levels of IL-10 when treated with B.
burgdorferi in vitro, which is important in regulating bacterial
persistence [49] and immune response [46,66–68]. Data from
Figure 6B also showed that many macrophages in joints of infected
B6 and B6 miR-146a2/2 mice express the alternatively activated
macrophage marker MRC1. While it is difficult to accurately
determine the range of macrophage phenotypes present in joints,
we used BMDMs pretreated with IL-10 as an in vitro model to
study miR-146a effects on IL-10-stimulated macrophages.
BMDMs were treated with 1ng/ml IL-10 for 4 hours prior to
24-hour B. burgdorferi stimulation. Surprisingly, while pretreatment
with IL-10 led to an approximately 80% reduction in IL-6
production in B6 BMDMs, IL-10-mediated suppression of IL-6 in
B6 miR-146a2/2 BMDMs was drastically reduced, with only
,20% decrease in IL-6 production after IL-10 pretreatment,
indicating that IL-10 was unable to effectively suppress IL-6
expression in the absence of miR-146a. These data are consistent
with in vivo data showing consistently elevated IL-6 protein in
serum from 4 week-infected B6 miR-146a2/2 mice in Figure 4.
However, IL-10 pretreatment did lead to significantly reduced IL-
12 and TNFa production in both strains, as well as high
production of IL-10, after B. burgdorferi treatment, consistent with
an anti-inflammatory M2-like phenotype. Both IL-1b and CXCL1
remained higher in B6 miR-146a2/2 BMDMs compared to B6
BMDMs, although IL-1b levels were unaffected, and CXCL1
levels were modestly reduced by IL-10 pretreatment. Importantly,
levels of IL-12, TNF-a and IL-10 were very similar between the
two strains, suggesting there was no miR-146a-mediated defect in
M2 polarization in response to IL-10 pretreatment. This is
consistent with in vivo observations, where TNFa, IL-12 and IFNc
serum protein levels were not significantly elevated in B6 miR-
146a2/2 mice at 4 weeks post-infection, relative to B6 mice
(Figure 4B).
The role of microRNAs, including miR-146a, during inflam-
matory responses involves suppressing distinct mRNA targets,
depending on cell type [69]. It was therefore important to
determine the mRNA target most affected at the protein level by
the presence or absence of miR-146a in BMDMs. Immunoblot
analysis was performed on protein extracts from B6 and B6 miR-
146a2/2 BMDMs treated for 24 hours with B. burgdorferi to
measure protein levels of three targets of miR-146a, TRAF6,
IRAK1 and STAT1 (Figure 7B). TRAF6 protein expression was
elevated over two-fold in both resting and stimulated B6 miR-
146a2/2 BMDMs compared to B6, while protein levels of IRAK1
were similar between strains. STAT1 protein was also higher in
resting B6 miR-146a2/2 BMDMs compared to B6, but this
difference between strains was not observed after 24 hours
stimulation. Transcript analysis of Traf6, Irak1 and Stat1 also show
this trend (Figure 7C). It is interesting that in the case of TRAF6,
the difference observed at the protein level was greater than that
seen at the transcript level, where transcripts were typically only
30–50% greater in B6 miR-146a2/2 BMDMs vs. B6 BMDMs,
suggesting that miR-146a effect on translational inhibition is more
pronounced than its effect on mRNA stability. This is consistent
with a growing body of evidence suggesting that microRNA-
mediated translational repression is dependent on inhibition of
translation initiation, rather than mRNA degradation [70,71].
The difference between protein and transcript levels of these three
genes (Figure 7B, C) strongly suggests that posttranscriptional
regulatory mechanisms including, but not limited to, microRNA-
mediated repression, play an important role in determining
cellular protein levels. STAT1 is known to be regulated by a
large number of posttranslational modifications that affect function
[72]. Both STAT1 and IRAK1 protein levels have been shown to
be tightly regulated through ubiquitin E3 ligase-directed degra-
dation [73,74]. In the case of IRAK1 and STAT1, these data
suggest that miR-146a-independent regulatory mechanisms seem
to be dominant compared to miR-146a-mediated regulation.
Taken together, TRAF6 protein levels appear to be the most
sensitive to the presence or absence of miR-146a in myeloid cells,
and imply miR-146a-mediated translational repression of TRAF6
is required to properly regulate production of NF-kB-induced
cytokines in response to B. burgdorferi. The lack of difference in
STAT1 protein level is also consistent with a failure to observe
significant differences between B6 and B6 miR-146a2/2 mice in
the IFN response (Figures 4&5).
Macrophages lacking miR-146a have increased
phagocytic activity
One possible explanation for reduced numbers of B. burgdorferi in
joints of infected B6 miR-146a2/2 mice is that macrophages
lacking miR-146a are more highly phagocytic. In order to
measure phagocytic activity, peritoneal macrophages were col-
lected from B6 and B6 mir-146a2/2 mice and stimulated with
GFP-labeled B. burgdorferi for 1 or 2 hours at 10:1 multiplicity of
infection (MOI). Phagocytosis of GFP-B. burgdorferi was measured
by flow cytometry (Figure 8A&B). At both 1 and 2 hours post-
stimulation, peritoneal macrophages lacking miR-146a had
significantly higher numbers of GFP+ cells, as well as a higher
mean fluorescence intensity (MFI) for GFP in GFP+ macrophages.
These data suggest that there are more B6 miR-146a2/2
peritoneal macrophages associated with higher numbers of
bacteria than wild-type cells.
Flow cytometry was unable to distinguish localization of the cell-
associated bacteria. To determine whether GFP-B. burgdorferi were
intracellular or adhering to the cell surface, confocal microscopy
cheek bleed at 4 weeks post-infection, and IL-6, TNFa, IL-12 and IFNc protein concentration was measured by ELISA. Statistically significant
differences between groups by ANOVA followed by Tukey’s post-hoc test are indicated (*p,0.05, n$9 mice per group).
doi:10.1371/journal.ppat.1004212.g004
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was used to visualize the bacteria associated with peritoneal
macrophages. Peritoneal macrophages were stimulated with GFP-
B. burgdorferi at 100:1 MOI for 1 hour and stained for the lysosomal
protein LAMP1 (red), the macrophage-specific surface protein F4/
80 (blue), and nuclei were stained with DAPI (gray, Figure 8C).
Bacteria were visible adhering to cell surface (white triangle), inside
macrophage pseudopodia (white arrow) and inside cells associated
with LAMP1 (white chevron). While bacteria adhering to the cell
surface and inside pseudopodia had a spirochetal shape, bacteria
associated with lysosomes were amorphous, and formed bright
Figure 5. Effect of miR-146a in isolated joint cell populations early in infection. (A) FACS analysis of cells released from joint tissue of B6
mice uninfected or infected with B. burgdorferi for 7 or 14 days. Single-cell suspensions of tissue were prepared as described in materials and
methods, and cells were stained according to myeloid (CD45+ CD11b+), lymphoid (CD45+ CD11b2), endothelial (CD452 CD31+) or fibroblast-
enriched (CD452 CD312 CD29+) lineages, following gating to exclude debris, dead cells and cell doublets. (B) Cells sorted into various lineages
depicted in (A) were analyzed for transcript levels of Cxcl2, IL1b and Oasl2 in myeloid cells, Cxcl1 in fibroblast-enriched cells, and IFNc in lymphoid
cells, normalized to b-actin. Statistically significant differences between groups by ANOVA followed by Tukey’s post-hoc test are indicated (*p,0.05).
Data are representative of two independent experiments (n = 4 mice for each group).
doi:10.1371/journal.ppat.1004212.g005
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Figure 6. Myeloid cell recruitment is increased in infected joints of B6 miR-146a2/2 mice. (A) Representative flow cytometry analysis of
CD11b+ cells released from joint tissue of B6 or B6 miR-146a2/2 mice infected with B. burgdorferi for 2 or 4 weeks, following gating to exclude debris,
dead cells and cell doublets. Numbers indicate gate percentages. (B) Representative histogram showing MRC1 (Mannose Receptor, C type 1, CD206)
and Gr1 fluorescence intensity in macrophages (MQ), polymorphonuclear cells (PMNs) and monocyte gates, as shown in (A). Gray shaded area
indicates B6 mice and the black line indicates B6 miR-146a2/2 mice. Bar graph on right shows average mean fluorescence intensity of macrophages,
PMNs and monocytes isolated from 14 day-infected B6 or miR-146a2/2 mouse joints (n = 4). (C) Total numbers of myeloid cell populations in joints of
uninfected or B. burgdorferi-infected mice at 2 and 4 weeks post-infection from B6 or B6 miR-146a2/2 mice. Cell populations were identified by flow
cytometric analysis with macrophages defined as CD11b+ F4/80+ Ly6Clo, polymorphonuclear cells (PMNs) as CD11b+ Gr1hi Ly6Cint, and monocytes as
CD11b+ Gr1int Ly6Chi. Statistically significant differences between groups by ANOVA followed by Tukey’s post-hoc test are indicated (*p,0.05). For
selected values not reaching statistical significance cutoff, p values are listed. Representative of 2 independent experiments (n = 4 for each group).
doi:10.1371/journal.ppat.1004212.g006
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GFP puncta, indicative of bacterial degradation. These bright
GFP puncta were predominant throughout the entire sample, as
represented in the image in Figure 8C for B6 mice, and in Figure
S2 for B6 miR-146a2/2 mice. This indicates that phagocytosis
occurs very rapidly as previously reported [65], and the flow
cytometry analysis infers that miR-146a modulates the level of
phagocytic activity. Although the mechanism is unknown, similar
transcript levels were seen for TLR2, CD14, as well as the
scavenger receptor MARCO (data not shown), which have been
recently implicated in B. burgdorferi uptake [75–78]. Previous
reports showing phagocytosis influencing cytokine production in
human mononuclear cells [78], and B6 MyD882/2 BMDMs
being defective in bacterial internalization [79], are consistent with
B6 miR-146a2/2 BMDMs having elevated cytokine production
and enhanced phagocytic activity (Figure 7, Table 3, Figure 8).
While more research is necessary to elucidate this mechanism,
these data suggest that B6 miR-146a2/2 macrophages have
enhanced phagocytosis, and may help explain why joint tissue
from B6 miR-146a2/2 mice contains fewer numbers of spir-
ochetes (Figure 2C).
Discussion
These data have allowed us to generate a model (Figure 9)
where miR-146a is upregulated during B. burgdorferi infection, and
acts as a nonredundant suppressor of inflammation and arthritis
(Figures 1–2). Interestingly, lack of miR-146a had no effect on
heart inflammation and carditis (Figure 3), indicating fundamental
differences between arthritis and carditis development. Differences
in carditis severity between B6 and C3H mice are believed to be
closely associated with differences in bacterial dissemination and
clearance between the two strains [80]. This is consistent with the
positive correlation between bacterial numbers and heart lesion
severity in B6, B6 miR-146a2/2 and C3H mice (Figure 3A–B),
and with previous reports showing no correlation between
quantitative trait loci associated with arthritis severity and
bacterial numbers in heart tissue [81,82]. Importantly, differential
contribution of NF-kB regulation was not predicted from studies
with mice deficient in TLR2 and MyD88, as both hearts and joint
tissues displayed increased presence of B. burgdorferi [18,19,83].
Numerous studies have revealed different mechanisms of
pathogenesis in carditis development and differing contributions
of innate and adaptive responses in bacterial clearance and
resolution of carditis and arthritis. For example, although antibody
response plays an essential role in resolution of arthritis, greater
roles of CD4+ T cells and iNKT cells as sources of IFNc are
reported in protection and resolution of Lyme carditis [55,60,84–
86]. Other gene knockout and cytokine blocking studies have
shown tissue-specific effects of IL-10 [46] and chemokines [51,62]
on arthritis and carditis severity. These results suggest future
microRNA studies on carditis should focus on those miRs known
to influence the balance of CD4+ T cells [87] and iNKT cell
function, such as miR-150 and miR-181a/b [88–90].
Myeloid cells respond to a variety of Borrelia stimuli through
TLRs that lead to activation of NF-kB and upregulation of
hundreds of genes involved in controlling infection and initiating
the adaptive response. miR-146a is also upregulated, and is an
important check on the amplitude and duration of the NF-kB
response. In the absence of this microRNA, this response is
dysregulated, leading to increased transcription of certain NF-kB-
inducible cytokines and chemokines in infected joint tissue,
primarily late in infection (Figures 4–5). Myeloid cells exhibit
excessive proliferation and infiltration into joint tissue of B6 miR-
146a2/2 mice, have increased phagocytic activity and produce
excess cytokines such as IL-1b, IL-6 and CXCL1, leading to
inflammation of synovial tissue and arthritis development
(Figures 6–8). Regulation of the inflammatory response via a
miR-146a-mediated negative feedback loop is critical for resolu-
tion of the NF-kB response during the persistent phase of
infection, and mice lacking this miRNA are poised to develop
arthritis upon infection with B. burgdorferi.
NF-kB activation in response to B. burgdorferi infection is a
double-edged sword. On one hand, NF-kB activation is critical in
mounting an effective immune response to control infection; on
the other hand, dysregulated activation leads to inflammation and
arthritis. Because of the dual nature of NF-kB in inflammation and
host defense, decoupling these two roles has been difficult.
Knockout models using B6 TLR22/2 or MyD882/2 mice have
shown the important role of NF-kB in host defense, but because
these mice have such a severe innate defect in bacterial defense,
elucidating the role of NF-kB in arthritis using these models has
remained difficult. The B6 miR-146a2/2 mouse model of Lyme
arthritis is unique in that it effectively decouples these two roles,
leaving the bactericidal function intact while increasing the
amplitude of proinflammatory NF-kB activation. This has allowed
us to identify its role in arthritis development, independent of its
role in host defense, and suggests that miR-146a could be a
valuable therapeutic target for control of inflammation without
compromising ability to clear an infection.
MicroRNAs are a unique class of regulatory molecules. Unlike
transcription factors, they do not act as on/off switches, rather
they function as ‘‘fine tuners’’ of gene expression [26]. We have
taken advantage of this property to decouple the roles of NF-kB in
host defense and inflammation. Young B6 miR-146a2/2 mice are
phenotypically similar to wild-type B6 mice, and it is only upon
chronic exposure to inflammatory stimuli that immunological
Table 3. mRNA expression of induced cytokines in BMDMs from B6 and B6 miR-146a2/2 mice after 6 and 24 hours stimulation
with B. burgdorferi.
Strain 6 hours 24 hours
IL1b IL6 TNFa IL1b IL6 TNFa
B6 56.262.5 0.00860.002 127.366.6 109.7612.7 1.0760.46 6.4260.58
miR-146a2/2 23668.7 0.0660.007 168.2614.7 446.8614.0 2.6760.35 7.9160.37
Fold D 4.2 7.5 1.3 4.1 2.5 1.2
Induced transcript levels of IL1b, IL6 and TNFa (normalized to 1000 b-actin) in B6 and B6 miR-146a2/2 BMDMs stimulated with B. burgdorferi for 6 or 24 hours. Data
shown are mean6SE, as well as fold difference (Fold D) of expression in miR-146a2/2 vs. B6. Transcript levels of uninfected cells were very low and similar between
strains (not shown). Representative of 3 independent experiments (n$3 for each experiment).
doi:10.1371/journal.ppat.1004212.t003
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defects are seen [29]. Consistent with this, endotoxin tolerance is
highly dependent upon miR-146a expression in THP-1 cells [91].
Using Lyme arthritis as a model, we have shown that mice lacking
this key miRNA fail to adequately maintain immune homeostasis,
and develop inflammatory arthritis during a chronic bacterial
infection (Figure 2, Table 2).
This model is also distinct from other mouse models of Lyme
arthritis. For example, C3H mice exhibit a robust Type I IFN
expression profile early in infection, which contributes to arthritis,
and is absent in the mildly arthritic B6 mouse [43,44,47]. This IFN
response was absent miR-146a2/2 mice, similar to B6. Further-
more, B6 IL102/2 mice, a model for Th1-mediated arthritis, have
Figure 7. Bone marrow-derived macrophages from B6 miR-146a2/2 mice are hyper-responsive to B. burgdorferi and have elevated
levels of TRAF6. (A) Analysis of cytokine secretion of B. burgdorferi-treated BMDMs. Bone marrow-derived macrophages (BMDMs) from B6 (black) or
B6 miR-146a2/2 (white) mice were pre-treated for 4 hours in the presence or absence of recombinant mouse IL-10. Following pretreatment, cells
were stimulated with B. burgdorferi for 24 hours. Cell supernatant was collected and secretion of IL-6, IL-1b, CXCL1, IL-12, TNF-a and IL-10 was
measured by ELISA. (B) Immunoblot analysis of TRAF6, IRAK1 and STAT1 in B. burgdorferi-treated BMDMs from B6 (WT) or B6 miR-146a2/2 (KO) mice.
BMDMs were stimulated with media alone or B. burgdorferi for 24 hours and cells were lysed using NP-40. Quantification was determined based on
band intensity, normalized to b-actin, with B6 (WT) value set to 1. (C) Traf6, Irak1 and Stat1mRNA levels were quantified using qRT-PCR, normalized to
b-actin. Significant differences between groups by ANOVA followed by Tukey’s post-hoc test are indicated (*p,0.05). Representative of at least 2
independent experiments (n = 3–4 for each group).
doi:10.1371/journal.ppat.1004212.g007
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a very pronounced IFNc signature beginning at 14 days post-
infection that persists for several weeks [48]. This pattern was also
not observed in the arthritic B6 miR-146a2/2 mice (Figures 4–5,
Figure S1). Additionally, while B6 miR-146a2/2 and B6 IL102/2
mice both exhibit increased bacterial clearance, likely due to an
enhanced myeloid response to phagocytosis of bacteria [63], only
B6 IL102/2 mice show enhanced antibody response [49]. It was
somewhat surprising that B6 miR-146a2/2 mice did not exhibit a
strong T-cell-mediated phenotype, based on parameters tested,
since other studies have shown an important role of miR-146a in
regulating Th1 responses [31,92]. It is possible that the elevated
myeloid response could eventually lead to a dysregulated T-cell
response in some cases. Indeed, several B6 miR-146a2/2 mice did
have elevated serum IFNc at 4 weeks post-infection, although this
was the exception rather than the rule, and average levels did not
achieve statistical significance compared to wild-type mice
(Figure 4C). It may also be possible that robust production of
IL-10 seen in B6 miR-146a2/2 mice is sufficient to suppress any
T-cell dysregulation due to lack of miR-146a. Nevertheless, the
results of this study show that arthritis is influenced principally by
hyperactive myeloid cell activation.
The role of miR-146a in regulating NF-kB activation was
consistent with the observed defect in downregulation of NF-kB-
dependent cytokines and chemokines IL-1b, IL-6, Cxcl1 and Cxcl2,
in B6 miR-146a2/2 mice at 4 weeks post-infection (Figure 4).
Dysregulation of Cxcl1 in these mice was particularly interesting
because previous studies have shown that C3H mice lacking
CXCL1 have reduced neutrophil infiltration and arthritis [61,62].
This neutrophil chemokine is tightly regulated both at the
transcriptional and posttranscriptional level by both TLR depen-
dent and cytokine dependent mechanisms [93]. Data from Figure 7
suggest that excess cytokine production by B6 miR-146a2/2
macrophages may lead to enhanced CXCL1 production by
resident cells in vivo. Therefore, miR-146a, expressed primarily in
leukocytes [29], likely has cell-extrinsic effects on nonhematopoie-
tic cell function and arthritis development. Recently, IL-6 has been
shown to be an important downstream target of miR-146a in
regulating hematopoiesis and myeloproliferation [29]. This is
Figure 8. B6 miR-146a2/2 peritoneal macrophages exhibit increased phagocytic activity. (A) Representative plots of peritoneal
macrophages isolated from B6 or B6 miR-146a2/2 mice and incubated with GFP-B. burgdorferi for 1 or 2 hours at 10:1 MOI. Box indicates GFP+
fraction, and number in top-right corner is percent GFP+. Control is using cells only. (B) Mean percent GFP+ and GFP mean fluorescence intensity for
flow analysis shown in (A). Representative of two independent experiments (n = 3 for each experiment). Significant differences between groups by
ANOVA followed by Tukey’s post-hoc test are indicated (*p,0.05). (C) Confocal images of B6 peritoneal macrophages incubated with GFP-B.
burgdorferi for 1 hour at 100:1 MOI. Panels are (from top-left) cell nuclei (gray, DAPI), GFP-B. burgdorferi (green), lysosomes (red, LAMP-1), cell
membrane (blue, F4/80), bright-field and overlaid images. White bar indicates scale. White arrow shows a bacterium associated with a macrophage
pseudopod, chevron indicates bright GFP puncta associated with intracellular lysosomes, and triangle indicates a cell surface-associated bacterium.
Representative of two biological replicates. Similar images of B6 miR-146a2/2 macrophages can be found in Figure S2.
doi:10.1371/journal.ppat.1004212.g008
Figure 9. Model of miR-146a function as a suppressor of arthritis during persistent B. burgdorferi infection. Regulatory role of miR-146a
in myeloid cells present in joint tissue as a negative regulator of Toll-like receptor (TLR) signaling through suppression of adaptor proteins,
particularly TRAF6.
doi:10.1371/journal.ppat.1004212.g009
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consistent with increased IL-6 production shown in Figure 4 and
Figure 7, and corresponding increase in myeloid cell infiltration
into joint tissue (Figure 6). Thus, miR-146a-mediated regulation of
several cytokines and chemokines likely has a combined effect on
inflammatory responses.
Increased phagocytic activity, as well as elevated IL-1b
production (Figures 7–8) point to a previously unrecognized role
of miR-146a in phagocytosis and caspase-1 activation. While this
role remains to be elucidated, previous research has shown that B.
burgdorferi induces caspase-1-dependent IL-1b production, and
caspase-1 is important for inflammatory cell influx into joint tissue
[94]. Additionally, phagocytosis of live B. burgdorferi is a potent
activator of IL-1 b in human PBMCs [95].
Targets of miR-146a have been studied in many cell types, and
it is becoming increasingly evident that the modulatory effect of
miR-146a is dependent on cell type and physiological condition.
For example, STAT1 appears to be an important miR-146a target
in regulatory T-cells [92], and IRAK1 and TRAF6 both appear to
be important miR-146a targets in splenocytes [31] and human
monocytes [30]. This study highlights the particular role of miR-
146a targeting TRAF6 in myeloid cells (Figure 7), indicating that
miR-146a function is, to a certain degree, cell type-specific.
Importantly, several observations in the B6 miR-146a2/2 mouse
model are recapitulated in Lyme disease patients. Joint fluid and
synovial tissue from antibiotic-refractory Lyme arthritis patients
contain higher levels of IL-6 and IL-1b, as well as Th1 cytokines
and chemokines, compared with patients whose arthritis is
resolved after antibiotic treatment, and IL-1b remains elevated
in these treatment-refractory patients long after antibiotic therapy
[96,97]. Thus, the B6 miR-146a2/2model of Lyme arthritis could
be a useful tool in further understanding how regulation of NF-kB
is related to Lyme disease pathogenesis.
Materials and Methods
Ethics statement
Mice were housed in the University of Utah Comparative
Medicine Center (Salt Lake City, UT), following strict adherence
to the guidelines according to the National Institutes of Health for
the care and use of laboratory animals, as described in the Guide
for the Care and Use of Laboratory Animals, 8th Edition.
Protocols conducted in this study were approved and carried out
in accordance to the University of Utah Institutional Animal Care
and Use Committee (Protocol Number 12-01005). Mouse
experiments were performed under isofluorane anesthesia, and
every effort was made to minimize suffering.
Mice, bacterial cultures and infections, and assessment of
arthritis severity
C3H, C57BL/6 and B6.129P2-IL-10tm1Cgn/J (B6 IL102/2)
mice were obtained from Jackson Laboratories. B6 miR-146a2/2
KO mice on a pure C57BL/6 background were generated as
described [28]. Mice were infected with 26104 B. burgdorferi strain
N40 (provided by S. Barthold, University of California, Davis, CA)
by intradermal injection into the skin of the back. Infection was
confirmed in mice sacrificed before 14 d of infection by culturing
bladder tissue in BSK II media containing 6% rabbit serum
(Sigma-Aldrich), phosphamycin and rifampicin. ELISA quantifi-
cation of B. burgdorferi-specific IgM and IgG concentrations was
used to confirm infection in mice sacrificed at and after 14 d of
infection as described [17]. Ankle measurements were obtained
using a metric caliper. Rear ankle joints were prepared for
assessment of histopathology by removal of the skin and fixation of
tissue in 10% neutral buffered formalin. Decalcified joints were
embedded in paraffin, sectioned at 3 mm, and stained with H&E.
Each slide was scored from 0 to 5 for various aspects of disease,
including polymorphonuclear leukocyte (PMN) and mononuclear
cell (lymphocytes, monocytes, macrophages) infiltration into
inflammatory processes, tendon sheath thickening (hypertrophy
and hyperplasia of surface cells and/or underlying dense sheets of
cells resembling immature fibroblasts, synoviocytes, and/or
granulation tissue), reactive/reparative responses (periosteal hy-
perplasia and new bone formation and remodeling), and overall
lesion (composite score based on all lesions observed in 6–8
sections per joint), with 5 representing the most severe lesion, and
0 representing no lesion. Ankle measurements and arthritic lesions
were assessed in coded samples.
Hearts of B6, B6 miR-146a2/2 and C3H mice were assessed
for carditis by histopathologic evaluation at 3 weeks post-
infection. Hearts were fixed in 10% neutral buffered formalin,
embedded in paraffin and sectioned at 3 mm, and stained with
H&E. Lesion scoring was performed in a blinded fashion
based on a composite of 11 sections per sample, with a score of
5 representing the maximum lesion and 0 representing no
lesion.
miRNA microarray
Microarray analysis was performed with the assistance of the
University of Utah Microarray and Bioinformatics core facilities.
Whole joint RNA was purified from mouse joints (3–4 mice per
sample group) using miRNeasy kit (Qiagen). RNA quality was
determined using a Bioanalyzer 2100 and RNA 6000 Nano Chip
(Agilent Technologies). Agilent Mouse miRNA microarray v2
(8615k) was hybridized with Cyanine-3 labeled miRNA (using
100 ng total RNA) using the Agilent one-color GE hybridization
and wash kit. Slides were scanned in a G2505C Microarray
Scanner at 2 um resolution (Agilent Technologies). TIF files
generated from the scanned microarray image were analyzed in
the Agilent Feature Extraction Software (v.10.5), which was used
to calculate feature intensities, background measurements and
statistical analyses. Data sets for each biological sample were then
filtered and log(2) transformed using an in-house java script, and
were uploaded into Geospiza GeneSifter Analysis Edition (Perkin
Elmer). Pair-wise analysis between groups was performed using a
quality cutoff for both groups of 1, normalizing to median values,
with a cutoff value of 2-fold change compared to uninfected
controls.
Isolation of DNA from ear tissue and quantification of B.
burgdorferi
DNA was prepared from ear tissues frozen at the time of
sacrifice. Tissue was incubated in 50 mM NaOH for 1 hour at
93uC and neutralized with 1M Tris (pH 8). Quantification of
B. burgdorferi recA normalized to the mouse nidogen was
performed using a Roche LC-480 using previously published
primers [18].
Preparation of single-cell suspensions from mouse tissue
Single-cell suspensions were prepared as previously de-
scribed [43]. Skin was removed from rear ankle joints and
digested for 1 h at 37uC in RPMI 1640 containing 0.2 mg/ml
purified enzyme blend for tissue dissociation (Roche) and
100 mg/ml DNase I (Sigma-Aldrich), following partial removal
of tissue from bone using 20-gauge syringe needles. Single cell
suspension was filtered through a 100 mm cell strainer and red
blood cells were lysed using ammonium-chloride-potassium
(ACK) lysing buffer.
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Isolation of RNA and quantitative RT-PCR
For all experiments examining expression in heart and joint
tissue, RNA was purified from the heart or tibiotarsal joints with
the skin removed. Tissue was immediately immersed in RNA
stabilization solution (Qiagen) and stored at 280uC. Total RNA
was recovered from homogenized tissue using the miRNeasy kit
(Qiagen). For FACS-sorted cell populations, sorted cells were
collected directly in flow tubes containing 0.5 ml RNA stabiliza-
tion solution (Qiagen) and RNA was recovered using the
miRNeasy kit (Qiagen). RNA from BMDMs was recovered using
guanidium thiocyanate-phenol-chloroform extraction reagent (In-
vitrogen). RNA recovered from tissue and cells was reverse
transcribed, and transcripts were quantified using a Roche LC-480
according to our previously described protocols [47]. For mature
miRNA quantification, cDNA was synthesized using the mercury
Locked Nucleic Acid Universal RT microRNA PCR, Polyade-
nylation and cDNA synthesis kit (Exiqon), and miR-146a, 5S
rRNA Locked Nucleic Acid primer sets were used (Exiqon) to
quantify miRNA using a Roche LC-480. Other primer sequences
used in this study were as follows: Itgam (CD11b) FWD (59-
CCTTCATCAACACAACCAGAGTGG-39) REV (59- CGAGG-
TGCTCCTAAAACCAAGC-39), Irak1 FWD (59-TGTGCC-
GCTTCTACAAAGTG-39) REV (59-TGTGAACGAGGTCA-
GCTACG-39), Traf6 FWD (59-AAGCCTGCATCATCAAAT-
CC-39) REV (59-CTGGCACTTCTGGAAAGGAC-39). Primer
sequences for B. burgdorferi 16S rRNA, b-actin, Il1b, Stat1, Tnfa,
Oasl2 [47], Va14, F4/80 [48] Il10, Ifng, Cxcl10, Il6 [44] Cxcl1,
Cxcl2, Pecam1 (CD29), and Ptprc (CD45) [43] can be found in
indicated citations.
Flow cytometry
All flow cytometry data were analyzed using FlowJo (v.5)
software. Sorting experiments were performed using a BD
FACSAria II. All other FACS data were collected on a BD
LSRII flow cytometer. 7-aminoactinomycin D (eBioscience) or
DAPI (Invitrogen) was used in all experiments, and dead cells and
cell doublets were excluded from analyses. All Abs used for flow
cytometry were purchased from either BioLegend or eBioscience.
Unconjugated Fc blocking Ab (clone 93; BioLegend) was included
in all Ab-labeling experiments. Position of gates for sorting and
analysis was based on analysis of appropriate isotype controls.
Fluorochrome-conjugated Abs and isotype controls used in this
study were as follows: APC/Cy7-conjugated anti-CD11b (M1/70)
and anti-CD45.2 (104); FITC-conjugated anti-CD8a (53-6.7),
anti-CD11b (M1/70) and anti-Gr-1 (RB6-8C5); PerCP/Cy5.5-
conjugated anti-Ly6C (HK1.4), anti-CD4 (RM4-4) and anti-CD31
(390); PE-conjugated anti-F4/80 (BM8) anti-LAMP-1 (1D4B) and
anti-NK1.1 (PK136); PE/Cy-7–conjugated anti-CD4 (GK1.5) and
anti-TCR b (H57-597); APC-conjugated anti-CD206 (MMR) and
anti-F4/80 (BM8); and Brilliant Violet 605-conjugated anti-B220
(RA3-6B2). Confirmation of cell sorting efficiency was performed
using qRT-PCR of surface markers used.
Bone marrow-derived macrophage stimulation
Bone marrow-derived macrophages (BMDMs) were isolated
from the femurs and tibias of mice, as previously described [98].
Macrophage cultures were plated in 12-well plate at a density of
66105/ml in media containing the serum replacement Nutridoma
(Roche) and stimulated with live B. burgdorferi cN40 (7.56106/ml).
Priming of macrophages was performed by pre-incubating cells
with 1 ng/ml mouse recombinant IL-10 for 4 hours prior to
addition of B. burgdorferi. After 24 hours, cell supernatants were
collected and analyzed by enzyme-linked immunosorbent assay
(ELISA). For expression analysis, RNA was collected from cells at
6 hours and 24 hours post-stimulation, and mRNA quantification
was performed by qRT-PCR using methods described above.
ELISA analysis of mouse serum and cell supernatant
Blood from mice was obtained by submandibular puncture at
the time of euthanasia. Blood was allowed to clot, centrifuged, and
serum was collected and stored at 220uC prior to analysis. Cell
supernatant was used immediately or stored at 220uC prior to
analysis. Cytokine concentration in serum samples and cell
supernatant was detected by sandwich ELISA using capture and
biotinylated antibodies against mouse IL-1b (clones B122 and
Poly5158, Biolegend), IL-6 (clones MP5-20F3 and MP5-32C11,
BD Biosciences), IL-10 (clones JESS-2A5 and SXC-1, BD
Biosciences) IL-12 (clones C15.6 and C17.8, BD Biosciences).IFNc
(clones R46A2 and XMG1.2, BD Biosciences), TNFa (clones
G281-2626 and MP6-XT3, BD Biosciences) and CXCL1 (clone
48415 and Cat BAF453, R&D Systems).
Immunoblot analysis
Cells were washed and lysed at 4uC. with NP-40 lysis buffer
(0.5% NP-40) for 1 hour followed by boiling for 5 minutes in SDS
sample buffer. Protein concentration was measured using a BCA
protein assay (Thermo Scientific). Proteins were separated by
polyacrylamide gel electrophoresis (PAGE) and transferred over-
night at 4uC. onto an Immobilon-P membrane (Millipore).
Membrane was blocked with 5% milk in TBST and stained with
the following antibodies: rabbit anti-TRAF6 (clone H-274, Santa
Cruz), rabbit anti-IRAK1 (clone D51G7, Cell Signaling) rabbit
anti-STAT1 (Cell Signaling #H9172S) and rabbit anti-b-actin
(clone 13E5, Cell Signaling) as a loading control. Horseradish
peroxidase-conjugated goat anti-rabbit IgG (BioRad) was used as a
secondary antibody prior to incubation with enhanced chemolu-
minescent substrate (Thermo Scientific). Membrane was exposed
to autoradiography film (GeneMate) and developed using a
medical film processor (SRX-701, Konica Minolta).
Phagocytosis assay
Mice received an intraperitoneal (IP) injection of 3 ml of 3%
thioglycollate 4 days prior to harvesting of peritoneal macrophag-
es. Macrophages were removed from sacrificed mice by IP
injection of 5 ml ice-cold PBS. Red blood cells were lysed using
ACK lysis buffer. 56105 cells were allowed to adhere to a 12-well
plate in RPMI+10% FBS for 4 hours, after which cells were
washed and unadhered cells removed. 56106 B. burgdorferi strain
N40 constitutively expressing GFP under the flaB promoter [99] (a
gift from Dr. Jay Carroll) were added to cells in RPMI.B (75%
RPMI+10% FBS+25% BSKII), as described [100], plates were
centrifuged at 500 g for 5 minutes and incubated for 1 or 2 hours.
After which cells were washed gently 36 in warm PBS and gently
removed from the plate using a cell scraper. Cells were washed 26
with ice-cold PBS and supernatant discarded following centrifu-
gation. Washed cells were then resuspended in flow buffer and
analyzed by flow cytometry using a BD LSRII flow cytometer. As
a negative control, untreated cells and cells incubated with
unlabeled B. burgdorferi N40 were used.
Confocal microscopy
Peritoneal macrophages were harvested as described above and
allowed to adhere to the surface of etched microscope cover slides
for 4 hours. Cells were incubated with GFP-B. burgdorferi for
1 hour at a 100:1 MOI as described above, followed by 46washes
with warm PBS, fixed in 4% paraformaldehyde, and incubated
with antibody blocking solution (3% BSA 0.05% milk 0.2%
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Tween20 in PBS) for 1 hour at RT. Cells were then stained with
PE-conjugated LAMP-1, APC-conjugated F4/80 and DAPI for
1 hour in antibody solution (1% BSA 0.02% Tween20 in PBS),
washed and mounted onto a glass slide using fluorescent mounting
reagent (Calbiochem EMD Millipore). Confocal imaging was
performed on a FV1000 inverted confocal microscope (Olympus)
using FV10-ASW software (Olympus). Images were taken using a
606oil lens with a 102461024 26zoom, and captured at a plane
dissecting the middle of cell nuclei. All imaging was performed at
the University of Utah Cell Imaging Core Facility, with the
assistance of Dr. Christopher Rodesh.
Data and statistical analysis
Microarray data statistical analysis was performed using the
Agilent Feature Extraction Software (v.10.5) and Geospiza
GeneSifter Analysis Edition (Perkin Elmer), as described. Raw
and adjusted p values were derived by Welch’s t test with
Benjamini and Hochberg correction, using a raw p value cutoff of
p,0.05 signifying statistical significance. All other graphical data
represent the mean 6 SEM. Statistical analysis was performed
using Prism 5.0c software. Multiple-sample data sets were
analyzed by one-way ANOVA with Dunnet’s or Tukey’s post
hoc test for pair-wise comparisons, as appropriate and indicated in
figure legends. Two-sample data sets were analyzed by Student t
test. Categorical data for histopathology was assessed by Mann-
Whitney U test. Statistical significance indicated in figure legends.
Supporting Information
Figure S1 Lymphocyte infiltration into joints of B.
burgdorferi-infected mice are similar between WT and
miR-146a2/2 mice. Flow cytometry analysis of lymphoid cells
released from joint tissue of B6 or B6 miR-146a2/2 mice infected
with B. burgdorferi for 2 or 4 weeks, following gating to exclude
debris, dead cells and cell doublets. Cell lineages defined as
follows: T cells (CD45+ TCRb+), B cells (CD45+ B220+), and NK
cells (CD45+ NK1.1+). No significance was observed between any
groups by ANOVA followed by Tukey’s post-hoc test (*p,0.05).
(TIFF)
Figure S2 Confocal images of B6 miR-146a2/2 perito-
neal macrophages incubated with GFP-B. burgdorferi.
Panels are (from top-left) cell nuclei (gray, DAPI), GFP-B.
burgdorferi (green), lysosomes (red, LAMP-1), cell membrane (blue,
F4/80), bright-field and overlay fields. White bar indicates scale.
(TIF)
Table S1 MicroRNAs with greater than 2-fold change in
expression in joints of mouse strains, based on Agilent
miRNA microarray analysis. All microRNAs with greater
than 2-fold change in expression in B. burgdorferi-infected joints of
B6, C3H and B6 IL-102/2 mice at one and two weeks post-
infection, compared to uninfected controls, based on Agilent
mouse miRNA microarray. Shown is gene name, fold-change,
direction of fold-change, p-value and adjusted p-value. Signifi-
cance was determined using Welch’s t-test with Benjamini and
Hochberg correction (p,0.05, n= 3–4 mice per group).
(XLSX)
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